# EPLERENONE
> **ANDA208283** · Abbreviated New Drug Application (Generic) · Sponsor: BRECKENRIDGE · Approved 2018-09-14
## Drug
- **FDA Application Number:** ANDA208283
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EPLERENONE
- **Generic name:** EPLERENONE
- **Active ingredients:** EPLERENONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRECKENRIDGE
- **Manufacturer:** Breckenridge Pharmaceutical, Inc.
- **First approval:** 2018-09-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208283)
---
*AI Analytics · CC0 1.0*